Next Generation Antibodies
Discover the next generation of antibodies and how biotech is driving innovation in industrial companies and academic labs for human health
Date and time
Location
8 Av. des Sciences
8 Avenue des Sciences 91190 Gif-sur-Yvette FranceAbout this event
- Event lasts 2 hours
Explore the next generation of antibodies and how biotech is transforming human health through partnerships with industrial companies and academic labs.
📅 Date: December 2nd, 2024
🕛 Time: 12:00 PM - 14:00 PM
📍 Location: : Lumen – 8 Av. des Sciences, 91190 Gif-sur-Yvette
🌟 Hear from Emilia McLaughlin, CEO of Kyron.Bio, a startup developing innovative antibody solutions to combat cancer and autoimmune diseases.
🧬 Learn from Claus Haase, Senior Vice President at Symphogen A/S - a Servier company, as he explores how industrial companies are leading innovation in developing next-generation antibodies for human health.
🔬 Bernard Maillère, Director of Research in Immunology at Université Paris-Saclay and coordinator of the ANR-funded project ACCREDIA (Accelerating Research for Early Development of Innovative Antibodies), will provide unique insights into accelerating antibody innovation through academic excellence.
🎤 The panel will be moderated by Estefania Tumbaco, a doctoral researcher at Servier, supervised by Marc Pallardy, who brings extensive experience and collaboration with Bernard Maillère—ensuring an engaging, well-informed discussion.
🤝 Networking with industry leaders: Connect with speakers, other guests and La BioTeam—a collaboration of biotech leaders from Spartners (Servier and BioLabs), Genopole, IncubAlliance, Kadans, and the Paris-Saclay Land Planning Authority.
This is a great opportunity to explore partnerships that can accelerate your biotech journey and foster innovation.
Agenda:
12:00 PM - 12:45 PM
- Opening keynote:
Stéphanie TEA, Investment Project Manager – Paris-Saclay Development Authority. - Panel Discussion (Moderated by Estefania Tumbaco):
- Emilia McLaughlin: CEO of Kyron.Bio.
- Claus Haase: Senior Vice President, Symphogen A/S - a Servier company.
- Bernard Maillère: Director of Research in Immunology, Université Paris-Saclay.
12:45 PM - 2:00 PM
- Networking Session:
Meet and connect with industry leaders and key actors of the Paris-Saclay cluster.
🚀 Powered by #LaBioTeam: Your ultimate catalyst for biotech success, made up of:
✨ Genopole – Facilitating and accelerating the creation and development of life science companies.
⚡ #Spartners – Accelerating time-to-market for biotech companies
🔬 IncubAlliance Paris-Saclay – Public incubator for deeptech entrepreneurs.
🏗️ Kadans Science Partner – Built for innovation.
⚠️ Important Note:
Please register to secure your spot. All reservations are subject to final confirmation.